查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1933282

全球合约生产组织 (CRO) 市场：市场规模、市场占有率、成长率、行业分析、依类型、应用和地区划分的考虑因素以及未来预测 (2026-2034)

Contract Manufacturing Organization Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 107 Pages | 商品交期: 请询问到货日

价格

合约生产组织 (CRO) 市场的成长因素

全球合约生产组织 (CRO) 市场在医药和生技供应链中扮演着至关重要的角色，它使企业能够将药品生产业务外包，从而专注于研发和商业化等核心活动。合约生产组织 (CMO) 提供广泛的服务，包括活性药物成分 (API)、製剂开发、稳定性测试、包装和商业化生产，同时确保符合严格的监管标准，例如良好生产规范 (GMP)。

根据这份报告，全球合约生产组织 (CRO) 市场预计到 2025 年将达到 1,682.4 亿美元。预计到 2026 年，该市场将成长至 1,812.9 亿美元，到 2034 年将达到 3,412.3 亿美元，预测期内复合年增长率 (CAGR) 为 8.1%。北美在 2025 年引领全球市场，占市场占有率的 31.90%。这主要得益于其强大的生物製药生产基础设施以及先进疗法和生物製品外包业务的不断增长。

合约生产组织 (CRO) 市场趋势

影响 CMO 市场发展的关键趋势之一是生产流程中数位化和自动化程度的不断提高。 CMO 正在整合先进的数位技术、人工智慧和自动化生产系统，以提高效率、改善品质控制并降低营运风险。

向数位化和自动化无菌生产的转变正在加速发展，这种转变能够实现无纸化操作、增强可追溯性并更快地识别品质偏差。这一趋势有助于提高整体设备效率 (OEE)，同时加强对监管标准的遵守。此外，CMO 正在扩展其端到端生产解决方案，以应对现代药物开发日益复杂的挑战。

市场成长驱动因素

生物製剂和生物相似药生产外包的增加是推动 CRO（合约生产组织）市场成长的主要因素。全球慢性疾病负担日益加重，例如癌症、糖尿病和神经系统疾病，这加速了对复杂生物製剂的需求，而这些生物製剂需要专门的生产技术和基础设施。

製药公司越来越多地与合约生产组织 (CMO) 合作，以经济高效且可扩展的方式生产生物製剂和生物类似药。此外，对个人化医疗和基因疗法的日益关注也为拥有先进能力的 CMO 创造了新的机会。

另一个主要的成长驱动因素是 CMO 加大对扩大其製药生产能力的投资。为了满足不断增长的全球需求，CMO 正在大力投资新建工厂、扩大产能、开发连续生产流程和先进的分析技术。这些投资使 CMO 能够提供贯穿整个药物生命週期的综合服务，从而推动市场的长期成长。

限制因子

儘管成长前景强劲，但市场仍存在一些挑战。建立和扩大製药生产设施的高昂成本是一个主要的限制因素。新建生产设施需要大量资本投资、漫长的建设週期以及严格的监管批准。

此外，由于担心产品品质、资料安全和供应链依赖性，製药公司可能不愿意完全依赖合约生产组织 (CMO) 进行关键的生产营运。这些因素可能会限制新进入者的进入，并阻碍某些地区的市场扩张。

合约生产组织 (CRO) 市场：细分市场分析

依服务类型，市场可分为三个部分：原料药生产、成品药生产、包装。原料药生产部分占市场主导地位，预计到 2026 年将达到 54.28% 的市场占有率，这主要得益于为提高成本效益和营运灵活性而增加的原料药生产外包。

成品药部分占第二大市场占有率，这主要得益于对固体製剂和注射剂的需求不断增长，尤其是在新兴市场。包装领域占适中的市场占有率，这主要得益于合约生产商 (CMO) 越来越多地提供整合包装解决方案，以确保产品及时交付。

区域洞察

北美仍是领先地区，凭藉对生物製药生产的积极投资和战略联盟，预计到 2026 年市场规模将达到 574.5 亿美元。欧洲由于主要 CMO 的存在以及原料药生产设施的扩张，预计到 2026 年也将占相当大的市场占有率。

亚太地区已成为成长最快的地区，这得益于医疗基础设施的改善、药品出口的成长以及中国、日本和印度等国本土製药企业的崛起。

主要参与者趋势

市场高度分散，主要参与者包括 Lonza、Catalent、Thermo Fisher Scientific、三星生物製剂和无锡生物製剂。这些公司正致力于扩大生产能力、建立策略合作伙伴关係并加强服务，以增强其全球影响力。

目录

第一章：引言

第二章：摘要整理

第三章：市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机遇
  • 市场趋势

第四章：关键考虑因素

  • 合约生产组织 (CRO) 市场的技术进步
  • 主要国家的监管现况及概述
  • 关键产业趋势：併购、业务合作等
  • 新冠疫情对市场的影响

第五章 全球合约生产组织 (CRO) 市场分析：洞察与预测（2021-2034）

  • 市场分析、洞察与预测：依服务分类
    • 原料药生产
    • 成品
      • 固体製剂
      • 注射剂
      • 其他
    • 包装
  • 市场分析、洞察与预测：依地区
    • 北美
    • 欧洲
    • 亚太地区
    • 世界其他地区 (ROW)

第六章：北美合约生产组织 (CRO) 市场分析：洞察与预测（2021-2034）

  • 依国家分类
    • 美国
    • 加拿大

章节第七章 欧洲合约生产组织 (CRO) 市场分析：洞察与预测 (2021-2034)

第八章 亚太地区合约生产组织 (CRO) 市场分析：洞察与预测 (2021-2034)

第九章 世界其他地区 (ROW) 合约生产组织 (CRO) 市场分析：洞察与预测 (2021-2034)

第10章 竞争分析

  • 全球市场占有率分析(2025年)
  • 企业简介
  • Boehringer Ingelheim International GmbH
  • Almac Group
  • Recipharm AB
  • Dr. Reddy's Laboratories Ltd.
  • FAMAR Health Care Services
  • Lonza
  • Vetter Pharma-Fertigung GmbH &Co. KG
  • Jubilant Pharmova Limited
  • Catalent Inc.
Product Code: FBI102658

Growth Factors of Contract Manufacturing Organizations (CMO) Market

The global Contract Manufacturing Organizations (CMO) market plays a vital role in the pharmaceutical and biotechnology supply chain by enabling companies to outsource drug manufacturing activities and focus on core functions such as research, development, and commercialization. CMOs offer a wide range of services including API manufacturing, formulation development, stability testing, packaging, and commercial-scale production, while ensuring compliance with strict regulatory standards such as Good Manufacturing Practices (GMP).

According to the report, the global Contract Manufacturing Organizations (CMO) market size was valued at USD 168.24 billion in 2025. The market is projected to grow to USD 181.29 billion in 2026 and further reach USD 341.23 billion by 2034, registering a CAGR of 8.1% during the forecast period. North America dominated the global market in 2025, accounting for 31.90% market share, supported by strong biopharmaceutical manufacturing infrastructure and rising outsourcing of advanced therapies and biologics.

Contract Manufacturing Organizations (CMO) Market Trends

One of the major trends shaping the CMO market is the increasing adoption of digitization and automation in manufacturing processes. CMOs are integrating advanced digital technologies, artificial intelligence, and automated production systems to enhance efficiency, improve quality control, and reduce operational risks.

The shift toward digitalized and automated aseptic manufacturing is gaining momentum, as it enables paperless operations, improved traceability, and faster identification of quality deviations. This trend is strengthening compliance with regulatory standards while improving overall equipment effectiveness (OEE). Additionally, CMOs are increasingly offering end-to-end manufacturing solutions to meet the growing complexity of modern drug development.

Market Growth Factors

The rising outsourcing of biologics and biosimilars manufacturing is a key driver of the Contract Manufacturing Organizations (CMO) market growth. The increasing global burden of chronic diseases such as cancer, diabetes, and neurological disorders has accelerated the demand for complex biologics, which require specialized manufacturing expertise and infrastructure.

Pharmaceutical companies are increasingly partnering with CMOs to manufacture biologics and biosimilars in a cost-effective and scalable manner. Moreover, the growing focus on personalized medicine and gene therapies is creating new opportunities for CMOs with advanced capabilities.

Another major growth factor is the increasing investment by CMOs in expanding their drug manufacturing capacity. To meet rising global demand, CMOs are investing heavily in new facilities, capacity expansion, continuous manufacturing processes, and advanced analytical technologies. These investments enable CMOs to offer integrated services across the drug lifecycle, driving long-term market growth.

Restraining Factors

Despite strong growth prospects, the market faces certain challenges. High costs associated with establishing and expanding pharmaceutical manufacturing facilities act as a major restraint. Building a new production facility requires substantial capital investment, long timelines, and strict regulatory approvals.

Additionally, pharmaceutical companies may hesitate to fully rely on CMOs for critical manufacturing operations due to concerns related to product quality, data security, and supply chain dependency. These factors can limit the entry of new players and restrict market expansion in certain regions.

Contract Manufacturing Organizations (CMO) Market Segmentation Analysis

Based on service, the market is segmented into API manufacturing, finished product manufacturing, and packaging. The API manufacturing segment dominated the market with a 54.28% share in 2026, driven by the increasing outsourcing of API production to achieve cost efficiency and operational flexibility.

The finished product segment held the second-largest share, supported by growing demand for solid dosage forms and injectables, particularly in emerging markets. The packaging segment accounted for a moderate share, as CMOs increasingly provide integrated packaging solutions to ensure timely product delivery.

Regional Insights

North America remained the leading region, with a market value of USD 57.45 billion in 2026, driven by strong investments in biologics manufacturing and strategic collaborations. Europe accounted for a significant market share in 2026, supported by the presence of major CMOs and expansion of API production facilities.

Asia Pacific emerged as the fastest-growing region due to improving healthcare infrastructure, rising pharmaceutical exports, and increasing number of domestic drug manufacturers in countries such as China, Japan, and India.

Key Industry Players

The market is highly fragmented, with key players including Lonza, Catalent, Inc., Thermo Fisher Scientific Inc., Samsung Biologics, and WuXi Biologics. These companies focus on expanding manufacturing capacities, forming strategic partnerships, and enhancing service offerings to strengthen their global presence.

Conclusion

The global Contract Manufacturing Organizations (CMO) market is set to experience sustained growth through 2034, driven by increasing outsourcing of pharmaceutical manufacturing, rising demand for biologics and biosimilars, and continuous investments in advanced manufacturing technologies. While high capital requirements and regulatory complexities pose challenges, expanding healthcare needs, technological advancements, and strategic collaborations are expected to support long-term market expansion and maintain positive growth momentum over the forecast period.

Segmentation By Service

  • API Manufacturing
  • Finished Product
    • Solid Dosage Forms
    • Injectables
    • Others
  • Packaging

By Region

  • North America (By Service and Country)
    • U.S.
    • Canada
  • Europe (By Service and Country/Sub-region)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Service and Country/Sub-region)
    • India
    • China
    • Japan
    • Australia
    • Rest of Asia Pacific
  • Rest of the World (By Service)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Technological Advancements in Contract Manufacturing Organizations (CMO) Market
  • 4.2. Overview of Regulatory Scenario, By Key Countries/Region
  • 4.3. Key Industry Developments Mergers, Acquisitions, Partnerships, etc.
  • 4.4. Impact of COVID-19 on the Market

5. Global Contract Manufacturing Organizations (CMO) Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Service
    • 5.1.1. API Manufacturing
    • 5.1.2. Finished Product
      • 5.1.2.1. Solid Dosage Forms
      • 5.1.2.2. Injectables
      • 5.1.2.3. Others
    • 5.1.3. Packaging
  • 5.2. Market Analysis, Insights and Forecast - By Region
    • 5.2.1. North America
    • 5.2.2. Europe
    • 5.2.3. Asia Pacific
    • 5.2.4. Rest of the World

6. North America Contract Manufacturing Organizations (CMO) Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Service
    • 6.1.1. API Manufacturing
    • 6.1.2. Finished Product
      • 6.1.2.1. Solid Dosage Forms
      • 6.1.2.2. Injectables
      • 6.1.2.3. Others
    • 6.1.3. Packaging
  • 6.2. Market Analysis, Insights and Forecast - By Country
    • 6.2.1. U.S.
    • 6.2.2. Canada

7. Europe Contract Manufacturing Organizations (CMO) Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Service
    • 7.1.1. API Manufacturing
    • 7.1.2. Finished Product
      • 7.1.2.1. Solid Dosage Forms
      • 7.1.2.2. Injectables
      • 7.1.2.3. Others
    • 7.1.3. Packaging
  • 7.2. Market Analysis, Insights and Forecast - By Countries/Sub-region
    • 7.2.1. Germany
    • 7.2.2. France
    • 7.2.3. U.K.
    • 7.2.4. Italy
    • 7.2.5. Spain
    • 7.2.6. Scandinavia
    • 7.2.7. Rest of the Europe

8. Asia Pacific Contract Manufacturing Organizations (CMO) Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Service
    • 8.1.1. API Manufacturing
    • 8.1.2. Finished Product
      • 8.1.2.1. Solid Dosage Forms
      • 8.1.2.2. Injectables
      • 8.1.2.3. Others
    • 8.1.3. Packaging
  • 8.2. Market Analysis, Insights and Forecast - By Countries/Sub-region
    • 8.2.1. China
    • 8.2.2. Japan
    • 8.2.3. India
    • 8.2.4. Australia
    • 8.2.5. Rest of Asia Pacific

9. Rest of the World Contract Manufacturing Organizations (CMO) Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Service
    • 9.1.1. API Manufacturing
    • 9.1.2. Finished Product
      • 9.1.2.1. Solid Dosage Forms
      • 9.1.2.2. Injectables
      • 9.1.2.3. Others
    • 9.1.3. Packaging

10. Competitive Analysis

  • 10.1. Global Market Share Analysis (2025)
  • 10.2. Company Profiles (Overview, Services, SWOT analysis, Recent developments, strategies, financials (based on availability))
    • 10.2.1. Boehringer Ingelheim International GmbH
      • 10.2.1.1. Overview
      • 10.2.1.2. Services
      • 10.2.1.3. SWOT Analysis
      • 10.2.1.4. Recent Developments
      • 10.2.1.5. Strategies
      • 10.2.1.6. Financials (Based on Availability)
    • 10.2.2. Almac Group
      • 10.2.2.1. Overview
      • 10.2.2.2. Services
      • 10.2.2.3. SWOT Analysis
      • 10.2.2.4. Recent Developments
      • 10.2.2.5. Strategies
      • 10.2.2.6. Financials (Based on Availability)
    • 10.2.3. Recipharm AB
      • 10.2.3.1. Overview
      • 10.2.3.2. Services
      • 10.2.3.3. SWOT Analysis
      • 10.2.3.4. Recent Developments
      • 10.2.3.5. Strategies
      • 10.2.3.6. Financials (Based on Availability)
    • 10.2.4. Dr. Reddy's Laboratories Ltd.
      • 10.2.4.1. Overview
      • 10.2.4.2. Services
      • 10.2.4.3. SWOT Analysis
      • 10.2.4.4. Recent Developments
      • 10.2.4.5. Strategies
      • 10.2.4.6. Financials (Based on Availability)
    • 10.2.5. FAMAR Health Care Services
      • 10.2.5.1. Overview
      • 10.2.5.2. Services
      • 10.2.5.3. SWOT Analysis
      • 10.2.5.4. Recent Developments
      • 10.2.5.5. Strategies
      • 10.2.5.6. Financials (Based on Availability)
    • 10.2.6. Lonza
      • 10.2.6.1. Overview
      • 10.2.6.2. Services
      • 10.2.6.3. SWOT Analysis
      • 10.2.6.4. Recent Developments
      • 10.2.6.5. Strategies
      • 10.2.6.6. Financials (Based on Availability)
    • 10.2.7. Vetter Pharma-Fertigung GmbH & Co. KG
      • 10.2.7.1. Overview
      • 10.2.7.2. Services
      • 10.2.7.3. SWOT Analysis
      • 10.2.7.4. Recent Developments
      • 10.2.7.5. Strategies
      • 10.2.7.6. Financials (Based on Availability)
    • 10.2.8. Jubilant Pharmova Limited
      • 10.2.8.1. Overview
      • 10.2.8.2. Services
      • 10.2.8.3. SWOT Analysis
      • 10.2.8.4. Recent Developments
      • 10.2.8.5. Strategies
      • 10.2.8.6. Financials (Based on Availability)
    • 10.2.9. Catalent Inc.
      • 10.2.9.1. Overview
      • 10.2.9.2. Services
      • 10.2.9.3. SWOT Analysis
      • 10.2.9.4. Recent Developments
      • 10.2.9.5. Strategies
      • 10.2.9.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Contract Manufacturing Organizations (CMO) Market Revenue (USD billion) Forecast, by Service, 2021-2034
  • Table 2: Global Contract Manufacturing Organizations (CMO) Market Revenue (USD billion) Forecast, By Finished Product, 2021-2034
  • Table 3: Global Contract Manufacturing Organizations (CMO) Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 4: North America Contract Manufacturing Organizations (CMO) Market Revenue (USD billion) Forecast, by Service, 2021-2034
  • Table 5: North America Contract Manufacturing Organizations (CMO) Market Revenue (USD billion) Forecast, by Finished Product, 2021-2034
  • Table 6: North America Contract Manufacturing Organizations (CMO) Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 7: Europe Contract Manufacturing Organizations (CMO) Market Revenue (USD billion) Forecast, by Service, 2021-2034
  • Table 8: Europe Contract Manufacturing Organizations (CMO) Market Revenue (USD billion) Forecast, by Finished Product, 2021-2034
  • Table 9: Europe Contract Manufacturing Organizations (CMO) Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 10: Asia Pacific Contract Manufacturing Organizations (CMO) Market Revenue (USD billion) Forecast, by Service, 2021-2034
  • Table 11: Asia Pacific Contract Manufacturing Organizations (CMO) Market Revenue (USD billion) Forecast, by Finished Product, 2021-2034
  • Table 12: Asia Pacific Contract Manufacturing Organizations (CMO) Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 13: Rest of the World Contract Manufacturing Organizations (CMO) Market Revenue (USD billion) Forecast, by Service, 2021-2034
  • Table 14: Rest of the World Contract Manufacturing Organizations (CMO) Market Revenue (USD billion) Forecast, by Finished Product, 2021-2034

List of Figures

  • Figure 1: Global Contract Manufacturing Organizations (CMO) Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Contract Manufacturing Organizations (CMO) Market Value Share (%), by Service, 2025 & 2034
  • Figure 3: Global Contract Manufacturing Organizations (CMO) Market Value (USD billion), by Region, 2025 & 2034
  • Figure 4: North America Contract Manufacturing Organizations (CMO) Market Value (USD billion), by Service, 2025 & 2034
  • Figure 5: North America Contract Manufacturing Organizations (CMO) Market Value Share (%), by Service, 2025
  • Figure 6: North America Contract Manufacturing Organizations (CMO) Market Value (USD billion), By Country, 2025 & 2034
  • Figure 7: North America Contract Manufacturing Organizations (CMO) Market Value Share (%), By Country, 2025
  • Figure 8: Europe Contract Manufacturing Organizations (CMO) Market Value (USD billion), by Service, 2025 & 2034
  • Figure 9: Europe Contract Manufacturing Organizations (CMO) Market Value Share (%), by Service, 2025
  • Figure 10: Europe Contract Manufacturing Organizations (CMO) Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 11: Europe Contract Manufacturing Organizations (CMO) Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 12: Asia Pacific Contract Manufacturing Organizations (CMO) Market Value (USD billion), by Service, 2025 & 2034
  • Figure 13: Asia Pacific Contract Manufacturing Organizations (CMO) Market Value Share (%), by Service, 2025
  • Figure 14: Asia Pacific Contract Manufacturing Organizations (CMO) Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 15: Asia Pacific Contract Manufacturing Organizations (CMO) Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 16: Rest of the World Contract Manufacturing Organizations (CMO) Market Value (USD billion), by Service, 2025 & 2034
  • Figure 17: Rest of the World Contract Manufacturing Organizations (CMO) Market Value Share (%), by Service, 2025
  • Figure 18: Global Contract Manufacturing Organization (CMO) Market Share (%), By Company, 2025